Literature DB >> 3360861

Determination of nifedipine and its three principal metabolites in plasma and urine by automated electron-capture capillary gas chromatography.

B J Schmid1, H E Perry, J R Idle.   

Abstract

A sensitive, efficient, linear and reproducible capillary gas chromatographic method with electron-capture detection was developed for the quantitation of nifedipine and its primary metabolite M-I in plasma together with the urinary and principal metabolites M-II and M-III. On-column, rather than split-splitless, injection was employed to obviate oxidative degradation of nifedipine to M-I. The photosensitivity of nifedipine was re-examined under laboratory conditions and nifedipine was found to have a half-life in excess of two days when amber glassware and darkroom manipulations under red light were used. The method can determine nifedipine and its metabolites in plasma and urine after a single oral dose of 5 mg and can be applied to measure M-I production by human liver microsomes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3360861     DOI: 10.1016/0378-4347(88)80011-2

Source DB:  PubMed          Journal:  J Chromatogr


  5 in total

1.  Lack of effect of co-trimoxazole on the pharmacokinetics and pharmacodynamics of nifedipine.

Authors:  C Edwards; S Monkman; S Cholerton; M D Rawlins; J R Idle; R E Ferner
Journal:  Br J Clin Pharmacol       Date:  1990-12       Impact factor: 4.335

2.  The influence of food on the pharmacokinetics of 'biphasic' nifedipine at steady state in normal subjects.

Authors:  G H Rimoy; J R Idle; N K Bhaskar; P C Rubin
Journal:  Br J Clin Pharmacol       Date:  1989-11       Impact factor: 4.335

3.  Two deaths from intravenous nifedipine abuse.

Authors:  B N Purdue; G C Fernando; A Busuttil
Journal:  Int J Legal Med       Date:  1991       Impact factor: 2.686

4.  Comparison of short-acting versus extended-release nifedipine: Effects on hemodynamics and sympathetic activity in patients with stable coronary artery disease.

Authors:  John D Parker; Matthew D' Iorio; John S Floras; Corey B Toal
Journal:  Sci Rep       Date:  2020-01-24       Impact factor: 4.379

5.  A phase I study on the reversal of multidrug resistance (MDR) in vivo: nifedipine plus etoposide.

Authors:  P A Philip; S Joel; S C Monkman; E Dolega-Ossowski; K Tonkin; J Carmichael; J R Idle; A L Harris
Journal:  Br J Cancer       Date:  1992-02       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.